Stress, Psychological

1
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 2 programs with unclassified modality

Competitive Landscape

3 companies ranked by most advanced pipeline stage

J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
1
MinocyclinePhase 4Small Molecule2 trials
Active Trials
NCT06120140Recruiting300Est. Jan 2032
NCT06044090Completed10Est. Dec 2023
Verona Pharma
Verona PharmaUK - London
1 program
Self Help PlusN/A
Crescent Biopharma
1 program
Self Help PlusN/A1 trial
Active Trials
NCT03571347Completed459Est. Dec 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Johnson & JohnsonMinocycline
Johnson & JohnsonMinocycline
Crescent BiopharmaSelf Help Plus

Clinical Trials (3)

Total enrollment: 769 patients across 3 trials

NCT06044090Johnson & JohnsonMinocycline

Brain and Stress Study

Start: Sep 2022Est. completion: Dec 202310 patients
Phase 4Completed
NCT06120140Johnson & JohnsonMinocycline

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

Start: Feb 2024Est. completion: Jan 2032300 patients
Phase 2Recruiting
NCT03571347Crescent BiopharmaSelf Help Plus

Self Help Plus for Asylum Seekers and Refugees in Europe

Start: Sep 2018Est. completion: Dec 2020459 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 769 patients
3 companies competing in this space